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Suppression of the T-cell lymphoproliferative response and downregulation of interleukin 2 (IL-2) produc-
tion by Toxoplasma gondii has been observed following in vivo infection. In this study, an experimental in vitro
murine system was developed to evaluate the kinetics of these responses. Normal splenocytes from uninfected
mice were stimulated with either concanavalin A or an anti-CD3 monoclonal antibody and cocultured with
Toxoplasma tachyzoites either directly or separated by a transwell. A progressive decline in the lymphoprolif-
erative response was observed as the concentration of parasites in culture increased. Neither heat-killed nor
formaldehyde-fixed parasites stimulated this downregulatory response by the splenocytes. A decline in IL-2
production was associated with the decrease in lymphocyte proliferation. The addition of an antibody to IL-10
or heat-inactivated anti-Toxoplasma sera to the culture supernatant partially neutralized the inhibitory effect
on lymphocyte proliferation. Cytokine analysis of the responder splenocytes demonstrated a decrease in the
message for IL-2 and IL-2 receptor and an increase in IL-10. Together, these observations suggest that during
in vitro culture in a murine system, parasite antigens that stimulate the release of a soluble factor(s), such as
IL-10, that inhibits proliferation of mitogen-stimulated T cells are expressed.
Suppression of the host immune system by different intra-
cellular parasites is well recognized. Earlier studies from our
laboratory and others have determined in mice that 7 days
after Toxoplasma gondii infection, both the T-cell mitogen and
parasite antigen-associated lymphoproliferative responses are
reduced (3, 13, 18). Associated with this reduced lymphocyte
response is a reduction in interleukin 2 (IL-2) and an increase
in IL-10, which appear to mediate, in part, the observed down-
regulation by T. gondii (13). Both activated macrophages and
lymphocytes secreting IL-10 (18) and the reactive intermedi-
ate, nitric oxide, inhibit T-cell proliferation in murine toxoplas-
mosis (3), and the expression of mRNA for IL-10 has been
observed in the brains of mice infected with T. gondii (2).
Murine IL-10 can downregulate the host immune response by
decreasing the production of IL-2 (11, 24) and inhibiting mi-
togen driven T-cell proliferation (9). Reversal of the inhibitory
response by exogenous IL-2 has been partially successful or
ineffectual in evaluating the response of lymphocytes to either
Trypanosoma cruzi-, T. gondii-, or malaria-infected mice (5, 6,
14). This discrepancy during acute T. gondii infection may be
due in part to the use of different parasite strains.
Because immune cells from infected mice are subject to a
wide range of regulatory processes in vivo, we developed an
experimental model to evaluate the downregulatory response
induced directly by the parasite following in vitro infection. In
this report, splenocytes were isolated from uninfected mice
and incubated with T. gondii in culture either in direct contact
with the host cells or physically separated from the host cells by
a semipermeable membrane. Our observations demonstrate
that as the number of parasites in culture increases, there is a
corresponding inhibition of both mitogen- and anti-CD3-
driven lymphoproliferation. This hypoproliferative response
could be partially neutralized by the addition of antibody to
IL-10 or heat-inactivated anti-Toxoplasma rabbit serum to the
culture, suggesting that T. gondii excretes or secretes a fac-
tor(s) that stimulates the production of the immune downregu-
latory cytokine, IL-10, in naive splenocytes.
MATERIALS AND METHODS
Parasites. For these studies, either the wild-type P (PLK) strain of T. gondii
(PTg) or the PTg-derived mutant, SAG1-deficient strain PTgB (15, 17) was used.
Parasites were maintained in our laboratory by in vitro passage in human fore-
skin fibroblasts at 378C in minimal essential medium containing 10% newborn
calf serum. Parasites were purified from human fibroblast cell culture as previ-
ously described (13), and parasite viability was determined by trypan blue exclu-
sion. For some experiments, parasites were heat killed or formalin fixed. For the
heat-killed parasite preparation, purified parasites were suspended in serum-free
medium at a concentration 2 3 108/ml and incubated at 568C for 50 min, washed
twice, and used fresh at various concentrations in 96-well plates. For the prep-
aration of formalin-fixed parasites, purified parasites were suspended in phos-
phate-buffered saline (PBS) and incubated for 1 h with 0.1% formalin at room
temperature, washed three times, and used at various concentrations (i.e., 10 3
105, 2 3 105, and 4 3 104 per well) and cell/parasite ratios (i.e., 1:5, 1:1, and 5:1).
Controls were done in parallel, using live parasites at the same cell/parasite ratios
(1:5, 1:1, and 5:1).
Lymphocyte preparation and phenotyping. Splenocytes were obtained from 5-
to 6-week-old female A/J mice. Erythrocytes were lysed by hypotonic shock with
0.2% ammonium chloride. The cells were washed in PBS and cultured in Iscove’s
medium containing 2 mM L-glutamine, 10 mM N-2-hydroxyethylpiperazine-N9-
2-ethanesulfonic acid (HEPES; pH 7.2), and 10% fetal bovine serum (HyClone
Laboratories, Logan, Utah). Viability of the lymphocytes was determined
(.99.5%) by trypan blue exclusion. Unless otherwise noted, the cell concentra-
tions were 23 105 cells per well in 96-well plates and 106 cells per well in 24-well
plates.
For phenotypic analysis of the responder population, 106 splenocytes were
incubated for 24 and 48 h with or without living T. gondii (106 parasite in a
Transwell-COL chamber) in the absence or presence of concanavalin A (ConA;
5 mg/ml) or cross-linked anti-CD3 monoclonal antibody (MAb; 5 mg/ml). The
washed cells were incubated with phycoerythrin (PE)-labeled anti-CD3ε1, PE-
labeled anti-CD4, or PE-labeled anti-CD8, fluorescein isothiocyanate labeled for
30 min at 48C, washed with PBS containing 1% bovine serum albumin, fixed with
1% formaldehyde, and analyzed by flow cytometry (13). For controls, cells were
stained with PE- or fluorescein isothiocyanate-labeled normal rat immunoglob-
ulin G (IgG).
Lymphocyte proliferation assays were performed in triplicate, using cells cul-
tured in Iscove’s medium at a concentration of 2 3 105 spleen cells per well with
different numbers of parasites to give a spleen cell/parasite ratio of 1:5, 1:1, or
5:1. In some experiments, a cell/parasite ratio of 4:1, 8:1, or 16:1 was used.
Separation of responder from parasites was done by using a transwell system
(Costar, Cambridge, Mass.). Mouse spleen cells (106) were cultured with various
concentrations of live parasites while separated from the responder cells by a* Corresponding author.
3442
transwell at cell/parasite ratios of 1:1, 4:1, and 16:1. ConA was added at the start
of culture and after 24 or 48 h of incubation at 378C, the proliferation was
measured by incorporation of [3H]thymidine (0.5 mCi per well; specific activity,
40 to 60 mCi/mmol; Amersham), and the results were expressed as stimulation
indices (SIs; SI 5 mean cpm for stimulated sample/mean cpm for unstimulated
sample).
Cross-linking of the anti-CD3 MAb (PharMingen, San Diego, Calif.) was
performed by coating 24-well plates with 14 mg of goat anti-hamster IgG (Jack-
son Immunology Research Laboratories, West Grove, Pa.) overnight at 48C.
After washing, the wells were incubated with 5 mg of the anti-CD3 MAb at 378C.
Naive splenocytes were added to the wells and separated from live parasites by
the semipermeable transwell membrane. DNA synthesis of proliferating lympho-
cytes was determined after 42 h by 6 h of [methyl-[3H]thymidine (ICN, Costa
Mesa, Calif.) incorporation.
Assays with an anti-PTg rabbit serum. Serum was obtained from rabbits
immunized over a 3-week period with a total dose of 100 mg of PTg extract. The
inoculum was prepared by repeat (four times) freezing-thawing of culture-de-
rived tachyzoites purified over a nylon wool column. The antibody response to
the PTg antigen was verified by enzyme-linked immunosorbent assay. The serum
was heat inactivated at 568C for 50 min and filtered before use. Splenocytes were
prepared from uninfected A/J mice as described above. Parasites were incubated
with heat-inactivated anti-PTg rabbit serum (dilution of 1:20) at 378C across a
semipermeable membrane from naive splenocytes that were incubated with
either ConA or medium alone. Heat-inactivated normal rabbit serum (dilution of
1:20) was used as a control. After 48 h of incubation, lymphocyte proliferation
was determined by [3H]thymidine incorporation. Data were expressed as SIs.
Cytokine analysis and production of NO. The presence of IL-2 in 18-h culture
supernatants was measured by proliferation of an IL-2-dependent murine T-cell
clone as previously described (12). The response was analyzed by probit analysis
and compared with the 50% maximal response obtained with standard recom-
binant IL-2. AMAb to IL-10 was used to investigate the effects of these cytokines
on parasite-induced splenocyte proliferation in the presence of ConA. IL-10
activity was determined by an inhibition assay using a rat anti-mouse IL-10
antibody (12 mg/ml; Genzyme, Cambridge, Mass.) and normal rat IgG (Sigma
Chemical Co., St. Louis, Mo.) as a control. Cells with parasites were incubated
with anti IL-10 for 30 min at 378C, after which either ConA or medium was
added. After 48 h of incubation, proliferation was determined by [3H]thymidine
incorporation. Data were expressed as SIs.
Nitrite in 48-h culture supernatants was measured by using Griess reagent
(10). Briefly, 0.05 ml of supernatant was mixed with 0.05 ml of Griess reagent
(0.5% sulfanilamide and 0.05% N-1-naphthylenedimine hydrochloride in 2.5%
H3PO4) and then incubated for 10 min at room temperature and read by a
spectrometer (A570). The nitrite concentration was calculated from a NaNO2
(Sigma) standard curve. The presence of IL-4 in 24-h culture supernatants was
measured by proliferation of a subline of the cell CTLL-2 line (CTLL-H) as
described previously (25).
RNA extraction and reverse transcription. To establish the optimum time
period for the expression of cytokine genes, PCR was performed with cells
cultured for either 6 or 18 h. To do the assay, 8 3 106 splenocytes, an amount
previously shown to be sufficient to allow for the detection of cytokine transcripts
(19), were activated with ConA in the presence or absence of equal number of
live parasites across a transwell at a cell/parasite ratio of 1:1. Extraction of RNA,
preparation of cDNAs from splenocytes, and PCR-assisted mRNA amplification
were done by a standard method as reported previously (19). Cytokine-specific
primer pairs (Clontech, Palo Alto, Calif.) and the primer for mouse IL-10
(Stratagene, La Jolla, Calif.) were obtained from a commercial source and used
according to the manufacturer’s suggestions. The oligonucleotide primer se-
quences used for PCR-assisted mRNA amplification are shown in Table 1.
RESULTS
Toxoplasma-infected splenocytes inhibit lymphocyte prolif-
eration. Uninfected mouse splenocytes were cocultured with
various concentrations of T. gondii in the presence of ConA,
and the level of proliferation was determined. As the number
of parasites in culture increased, there was a corresponding
decrease in the lymphoproliferative response as well as in the
production of IL-2 (Table 2). There was no significant differ-
ence in the degree of suppression induced by the wild-type or
mutant, SAG1-deficient parasites. Similar observations were
made when we used the transwell system in which the toxo-
plasmas were cocultured across the membrane from mitogen-
driven naive splenocytes, as shown in Table 3. The greatest
inhibition was observed at either a 4:1 (85%) or 1:1 (99%)
cell/parasite ratio (P , 0.005). To define whether this suppres-
sion was dependent on the presence of live parasites, different
concentrations of either heat-killed parasites or formaldehyde-
fixed parasites were used in a similar assay. As shown in Fig. 1,
none of these killed parasite preparations were able to inhibit
the lymphoproliferative response. Further, the major surface
protein SAG1 does not appear to be an important mediator of
this response, since there was no discernible difference in the
patterns of suppression induced by wild-type and mutant par-
asites. These findings indicate that the suppressive phenome-
TABLE 1. Primers used for PCR-assisted mRNA amplification
Primer Sequence
b-actin (540 bp)
59..............................................................................................................................59GTG CGC CGC TCT AGG CAC CAA 39
39..............................................................................................................................59CTC TTT GAT GTC ACG CAC GAT TTC 39
IL-4 (399 bp)
59..............................................................................................................................59ATG GGT CTC AAC CCC CAG CTA GT 39
39..............................................................................................................................59GCT CTT TAG GCT TTC CAG GAA GTC 39
IL-2R p55 (700 bp)
59..............................................................................................................................59ATG GAG CCA CGC TTG CTG ATG TTG 39
39..............................................................................................................................59C CAT TGT GAG CAC AAA TGT CTC CG 39
IL-2 (413 bp)
59..............................................................................................................................59TTC AAG CTC CAC TTC AAG CTC TAC AGC GGA AG 39
39..............................................................................................................................59GAC AGA AGG CTA TCC ATC TCC TCA GAA AGT CC 39
IFN-g (460 bp)
59..............................................................................................................................59-TGA ACG CTA CAC ACT GCA TCT TGG-39
39..............................................................................................................................59-CGA CTC CTT TTC CGC TTC CTG AG-39
IL-10 (274 bp)
Sense .......................................................................................................................226 GTGAAGACTTTCTTTCAAACAAAG 249
Antisense ................................................................................................................476 CTGCTCCACTGCCTTGCTCTTATT 499
TABLE 2. Production of IL-2 by parasite-stimulated spleen cellsa
Cell/parasite
ratio
production of IL-2 (pM)
Medium ConA
No parasite 1.66 0.6 56 6 7
16:1 1.0 6 0.01 27 6 6
4:1 0.5 6 0.01 20 6 7
1:1 0.6 6 0.01 8 6 4
a Supernatants from 24-h cultures with various splenocyte/parasite ratios were
tested for the presence of IL-2 by the CTLL-2 proliferation assay. The data
shown are the means 6 standard deviations of one typical experiment of four.
IL-2 production in mice infected at a cell/parasite ratio of 1:1 was significantly
lower than in uninfected mice (P , 0.05). For controls (medium only), the levels
of IL-2 were below the detectable threshold (,2 pM).
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non is dependent on the presence of live parasites and inde-
pendent of the major tachyzoite surface protein, P30 (SAG1).
Lymphocyte proliferation in response to anti-CD3 was then
used to distinguish if the inhibitory response was due to the
effect of mitogen stimulation on the responding lymphocytes.
CD3 molecules are important in the T-cell receptor-CD3 com-
plex and are necessary for signal transduction following anti-
gen binding. A transwell assay was performed to evaluate
whether the inhibitory response was observed in the presence
of cross-linked anti-CD3 (Table 4). Of note is that at the higher
cell/parasite ratio (1:1), 92% inhibition was observed when the
cells were stimulated with anti-CD3. These results indicated
that the factor(s) responsible for the observed inhibitory effect
was not dependent on the ConA-mediated response.
Kinetics of the lymphocyte inhibitory response by T. gondii.
Splenocytes were evaluated at different time points following
in vitro exposure to toxoplasmas for the ability to inhibit lym-
phocyte proliferation. Significant inhibition was observed with
the 24-h culture at a cell/parasite ratio of 4:1 (77%; data not
shown). However, consistent with the observations in Table 3,
maximal suppression of DNA synthesis was noted when the
responder cells were exposed to parasites for 48 h at a cell/
parasite ratio either of 8:1 (97%) or 4:1 (99%). Exogenous
IL-2 (2 nM) failed to reverse significantly the inhibitory effect
mediated by the live parasites in both the 24- and 48-h cultures.
Antibody neutralization of the inhibitory response. Previ-
ously, we reported that the inhibitory activity mediated by
splenocytes obtained from infected mice could be partially
neutralized by an antibody to IL-10 (13, 18). We next deter-
mined whether this cytokine was important in this in vitro
model of T. gondii-mediated immune suppression. For this
experiment, ConA-stimulated splenocytes (lower chamber)
were cultured in the presence of an antibody to IL-10 across
the transwell with different concentrations of live parasites
(upper chamber). As shown in Table 5, an anti-IL-10 MAb was
able to partially neutralize the inhibitory activity mediated by
live parasites at cell/parasite ratios of both 16:1 (25%) and 4:1
(30%).
Alternatively, some other factor(s) such as nitric oxide may
be partially responsible for the observed suppression (3, 18).
However, under the conditions of this experiment, there was
no detectable increase over the control in the degradation
product of nitric oxide metabolism when cells were cultured
with parasites at a ratio of 1:1 (99% inhibition) and stimulated
with either ConA (0.7 and 1.2 mM NO at 24 and 48 h, respec-
tively, compared with 0.5 and 1.0 mM NO at 24 and 48 h,
respectively, for mitogen-stimulated splenocytes without para-
sites) or an anti-CD3 MAb.
To evaluate if the parasites were expressing a soluble anti-
gen(s) responsible for the reduced proliferative response, a
blocking assay was performed. Various numbers of parasites
were incubated across a transwell with normal splenocytes in
the presence of a 1:20 dilution of heat-inactivated rabbit anti-
Toxoplasma serum, and the proliferative response to ConA
FIG. 1. Proliferative response of mouse splenocytes to T. gondii in vitro.
Splenocytes were incubated in triplicate wells with either wild-type (bars a and e)
or mutant (bars b and f) heat-killed parasites or wild-type (bars c and g) or
mutant (bars d and h) formaldehyde-fixed parasites at a cell/parasite ratio of 1:5
in the absence (bars a to d) or presence (bars e to h) of ConA (5 mg/ml). After
48 h, lymphocyte proliferation was measured by [3H]thymidine incorporation,
and the results were expressed as SIs. Control splenocytes incubated with either
wild-type or mutant live parasites in the presence or absence of ConA stimula-
tion showed an SI of ,5. Mean values for spleen cells from uninfected mice in
the presence and absence of ConA were 121,656 6 234 [SI 5 60]) and 2,020 6
30, respectively. This experiment was repeated three times.












No parasite 1.4 6 0.3 85 6 7.0 85 6 4.0
16:1 1.5 6 0.2 1.2 6 0.2 24 6 1.0 71 28 6 0.7 67
4:1 0.6 6 0.1 0.4 6 0.2 12 6 0.5 85 19 6 0.8 77
1:1 0.3 6 0.1 0.3 6 0.1 0.8 6 0.7 99 2 6 0.7 97
a Normal mouse splenocytes were cultured in the presence of ConA (5 mg/ml) and exogenous IL-2 (2 nM) across a transwell membrane from parasites at various
cell/parasite ratios. After 48 h of incubation at 378C, proliferation was measured by the amount of [3H]thymidine incorporated, and the results are expressed as SIs.
Control cultures are transwell inserts containing medium with or without mitogen in the absence of parasites. Results are expressed as the means6 standard deviations
of three experiments.
b Calculated as [(control 2 background) 2 (experimental 2 background)] control 2 background 3 100.
TABLE 4. Spleen cell responses to different concentrations of live






No parasite 40.6 6 4.5
16:1 2.6 6 1.3 32.0 6 5.7 21.0 6 7.0
4:1 3.8 6 2.4 16.0 6 6.0 62.0 6 10.0
1:1 2.4 6 1.6 3.2 6 1.8 92.0 6 4.2
a Normal mouse splenocytes were cultured in the presence of anti-CD3 across
a transwell membrane from parasites at various cell/parasite ratios. After 48 h of
incubation at 378C, proliferation was measured by the amount of [3H]thymidine
incorporated, and the results are expressed as SIs. Control cultures are transwell
inserts containing medium with or without mitogen in the absence of parasites.
Percent inhibition was calculated as for Table 3. Results are expressed as the
means 6 standard deviations of three experiments.
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was determined. This dilution was sufficient to restore the
proliferative response but did not alter the T-cell response of
normal mice. As shown in Table 6, heat-inactivated anti-PTg
rabbit serum was able to partially reverse the inhibitory effect
on the responder cells. This effect was most apparent at the
highest (16:1) cell/parasite ratio (36%) and not observed when
the ratio reached 1:1. Neither an antibody to SAG1 (P30), the
major surface protein of T. gondii, nor control rabbit serum
was able to block the inhibitory response.
Phenotypic analysis and cytokine expression by T. gondii-
infected splenocytes. A fluorescence-activated cell sorting
analysis to determine the phenotype of the responder T cells
was performed to better understand which T cells are most
affected by the suppressive factors produced by the splenocytes
in response to toxoplasmas. Parasites were cultured in a trans-
well and exposed to spleen cells obtained from uninfected mice
at a cell/parasite ratio of 1:1. There was no difference in the
expression of CD31, CD41, or CD81 T cells between unin-
fected control cells and cells cultured with live parasites at a 1:1
ratio for either 24 or 48 h (data not shown).
To ascertain the induction of cytokines, RNA was extracted
from responder cells after 18 h of incubation across a transwell
membrane with parasites and subjected to PCR. As shown in
Fig. 2, ConA stimulation of uninfected mouse splenocytes re-
sulted in the anticipated expression for IL-2, IL-2 receptor
(IL-2R) p55, IL-4, and gamma interferon (IFN-g). Of note is
the absence of transcript for IL-10 in these preparations. When
splenocytes were cultured in the presence of parasites (1:1
ratio, in the transwell system) and were stimulated with ConA
for 18 h, the transcripts for IL-2, and IL-2R p55 were no longer
detectable, but the message for IL-10 was evident. A transcript
for IL-10 cannot be distinguished in the parasite-only lane
(lane C). However, in the presence of ConA stimulation, en-
hanced expression of message for IL-10 can be observed (lane
D).
DISCUSSION
Our in vitro observations suggest that live T. gondii can
induce suppression of mitogen-driven lymphoproliferation of
mouse splenocytes. The hypoproliferative response is medi-
ated in part by IL-10 and cannot be significantly reversed by
the addition of exogenous IL-2 to the responder cells during
the first 24 or 48 h of in vitro infection. Our observations
further suggest that under the conditions of this experimental
murine model, the parasite is able to express parasite antigens
that elaborate this response.
The observed hypoproliferative response is independent of
both T-cell stimulus and parasite strain. In vitro exposure of
splenocytes to live T. gondii can reduce both ConA and cross-
linked anti-CD3-driven T-cell proliferative responses, similar
to the observations reported for T. cruzi (1, 22, 23). However,
the number of parasites able to induce this response differs
considerably from the number of T. cruzi needed to do so. In
our studies, this hypoproliferative response can be generated
with 5 to 16 times fewer parasites than splenocytes. Remark-
ably, even fewer parasites (cell/parasite ratio of 64:1) can stim-
ulate an 8 to 12% reduction in proliferation of normal spleno-
cytes to mitogen stimulation. This finding suggests that the
inhibitory molecules generated by the splenocytes in response
to parasite antigen are very potent inhibitors of lymphocyte
proliferation and furthermore require the simultaneous pres-
ence of both parasites and cells to be expressed.
Alteration in the production of IL-2 may be one mechanism
whereby the parasite is able to affect the normal host response
to infection. Previous reports from our laboratory and others
have documented this response in vivo within 7 days following
parasite infection in mice (3, 13, 18). The mechanism by which
IL-2 production is decreased is probably multifactorial. How-
ever, IL-10 may affect the production of IL-2 in response to
ConA. In our in vitro murine model, an antibody to IL-10
could partially neutralize the inhibitory effect. Murine IL-10
has been shown to inhibit cytokine production by impairing
antigen-presenting cell function (11, 21), perhaps by down-
regulating B7 expression on macrophages (9). Our data sug-
gest that parasite antigens are able to stimulate the production
of IL-10 in the presence of mitogen stimulation (Fig. 2). This
possibility is consistent with previous reports from our labora-
tory describing studies in which the experimental ex vivo
mouse model was used (13, 18). Those studies demonstrate
that splenocytes obtained from infected mice at day 7 postin-
fection exert an inhibitory effect on the lymphoproliferative
response in the presence of mitogen exposure. Similar obser-
vations have now been made in an in vitro human experimental
model (5a). However, in both the mouse and human studies,
the amplitude of this response is potentiated by the presence of
mitogen.
Reversal of suppression by exogenous IL-2 during acute
Toxoplasma infection has been observed. In a study by Chan et
al. (5), exogenous IL-2 was able to restore the reduced prolif-
erative response of splenocytes obtained from RH strain-in-
fected mice on day 3 but not day 6, whereas the proliferative
response of mouse splenocytes infected with a less virulent
strain of the parasite could be partially restored on both day 3
and day 6. In that study, splenocytes were used ex vivo postin-
fection. In our system, we used an in vitro model of infection
with naive splenocytes. This approach may result in the expres-
sion of different cytokines or perhaps T-cell costimulatory reg-
ulatory factors that can affect the fate of the unresponsive
lymphocytes.












No parasite 1.4 6 0.1 39.0 6 2 39.3 6 2
16:1 0.5 6 0.1 1.5 6 0 10.0 6 2 74 19.66 3 50
4:1 0.7 6 0 1.4 6 0 1.0 6 0 97 12.96 1 67
1:1 0.5 6 0.1 2.0 6 0.1 0.1 6 0 99 1.06 0.05 97
a Normal mouse splenocytes were cultured across a transwell membrane with parasites at various cell/parasite ratios for 48 h in the presence of ConA and an
anti-IL-10 MAb (12 mg/ml). Lymphocyte proliferation was measured by the amount of [3H]thymidine incorporated, and the results are expressed as means 6 standard
deviations of three experiments. Rat IgG was used as an isotype-matched control and failed to block the either the lymphocyte response to ConA (SI 5 39.2) or the
inhibitory response by the parasites on the splenocytes. The experiment was repeated three times.
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In this in vitro model, IL-10 appears to be an important
cytokine involved in the downregulatory response. Cytokine
analysis of the responding splenocyte population demonstrates
the downregulation of genes expressing IL-2 and IL-2R p55,
whereas the message for IL-10 was evident when uninfected
splenocytes were cocultured with live parasites at a cell/para-
site ratio 1:1 in the presence of ConA stimulation (Fig. 2). This
finding is consistent with recent observations from our labora-
tory that demonstrate similar downregulation of mRNA for
IFN-g expression and upregulation of IL-10 expression in
7-day infected splenocytes cultured in the presence of ConA.
We have recently demonstrated (13, 18) that significant neu-
tralization of the reduced proliferative response can be
achieved with anti-IL-10 concentrations ranging from 10 mg/ml
(P , 0.05) to 80 mg/ml (P , 0.01). Furthermore, this antibody
is able to increase the amount of IL-2 in the culture superna-
tant of parasite-infected splenocytes stimulated with ConA
(12a). The control antibody had no significant effect on reduc-
ing the lymphoproliferative effect of the 7-day infected culture
supernatant (P . 0.05). Together, these findings suggest that
the effect of an antibody to IL-10 is not parasite dose depen-
dent once a threshold value of IL-10 in the culture supernatant
is reached.
In this in vitro study, messages for IFN-g and IL-4 were
detectable whether uninfected splenocytes were stimulated
with or without ConA in the presence or absence of live par-
asites. The inhibitory role of IL-4 on IL-2 production might
also be considered (26). It has been reported that IL-10 can
affect proliferation and IL-2 production of human peripheral
blood T cells, while the production and mRNA levels of IL-4
and IFN-g are not affected by IL-10 (7). Moreover, IL-10 does
not appear to affect expression of the TCR T-cell receptor-
CD3 complex (7).
Since this response can be only partially neutralized by an
antibody to IL-10, other factors or cytokines may contribute to
this effect. Nitrogen intermediates, in particular nitric oxide,
have been shown to inhibit the proliferative response of T cells
(20). Although ex vivo studies by us and others suggest that NO
production may be in part responsible for the observed immu-
nosuppression in mice 7 days postinfection, our in vitro studies
indicate that this mechanism is at best only a minor constituent
of the downregulatory response. Another molecule that may
be involved in this response is transforming growth factor b
(TGF-b). Earlier studies in our laboratory have failed to dem-
FIG. 2. Cytokine gene expression of splenocytes cocultured with T. gondii.
Normal mouse splenocytes were incubated in the absence (lane C) or presence
(lane D) of ConA (5 mg/ml) across a transwell membrane with parasites at a ratio
of 1:1 for 18 h. Control splenocytes were incubated in the absence (lane A) or
presence (lane B) of ConA (5 mg/ml) without parasites. After the period of
incubation, the splenocytes were harvested, and mRNA was extracted and ana-



















































































































































































































































































































































































































































































































































































3446 HAQUE ET AL. INFECT. IMMUN.
onstrate blocking of the inhibitory effect ex vivo by antibody to
TGF-b, suggesting that TGF-b has only a limited role in the
downregulatory response (13).
From our observations, it appears that live parasites are
required for the production of inhibitory factor(s). In our
study, neither heat-killed nor formalin-treated parasites were
capable of inhibiting the host cell immune response. The re-
duced lymphoproliferative response could be partially neutral-
ized (38%) at a cell/parasite ratio of 16:1 when an anti-Toxo-
plasma rabbit serum was added to the culture. Since live
parasites excrete or secrete parasite antigens (4), we suggest
that T. gondii expresses specific molecules that stimulate this
immunosuppressive response in this in vitro mouse model.
Further, this parasite antigen appears to be soluble since it can
exert its immunological effect across a transwell membrane.
Circulating Toxoplasma antigens have been detected in the
sera of infected mice (reviewed in reference 16). It is perhaps
one of these circulating antigens that is responsible for the
observed immunosuppressive response. Active infection of the
macrophages with toxoplasmas may accentuate the immuno-
suppressive response, since reversal was only partially achieved
with anti-Toxoplasma sera.
The results of these studies demonstrate that T. gondii can
stimulate the production of various immune factors, including
IL-10, during an in vitro experimental model of infection. Re-
cent studies by Gazzinelli et al. have demonstrated the impor-
tance of IL-12 both in vitro and in vivo during acute and
chronic toxoplasmosis in mice. When peritoneal macrophages
are exposed to either live parasites or soluble tachyzoite anti-
gens in vitro, they are able to produce IL-12 as early as 2 days
postinfection (11a). In our studies, exposure of macrophages to
parasite antigens results in the production of IL-10, which
appears to be responsible in part for the observed immuno-
suppression in mice in both an in vivo and an in vitro system.
In contrast, immunosuppression by human monocytes may be
partially mediated by IFN-g (5a). By either mechanism, this
parasite is able to induce a state of transient immune suppres-
sion. This downregulatory response may prevent the host from
immune hyperreactivity; alternatively, it may be a mechanism
that allows the parasite to survive in a hostile environment.
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